Detection of Pseudomonas aeruginosa in patients with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 4, Issue 2 SUPPL., 2005, Pages 37-43

  Tramper Stranders, G A ^a   van der Ent, C K ^a   Wolfs, T F W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antibodies; Culture; Infection; PCR; Sensitivity; Serology

Indexed keywords

BACTERIAL TOXIN; BACTERIUM ANTIBODY; OUTER MEMBRANE PROTEIN;

ANTIBODY DETECTION; ANTIBODY RESPONSE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM DETECTION; DENSITY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOBLOTTING; LOWER RESPIRATORY TRACT INFECTION; LUNG FIBROSIS; MORBIDITY; MORTALITY; NONHUMAN; OROPHARYNX; PREDICTION; PSEUDOMONAS AERUGINOSA; REVIEW; SENSITIVITY ANALYSIS; SERODIAGNOSIS; SPUTUM CULTURE;

EID: 23644434785     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2005.05.009     Document Type: Article

References (51)

1. M.W. Konstan M. Berger Current understanding of the inflammatory process in cystic fibrosis: Onset and etiology Pediatr Pulmonol 24 1997 137-142
2. S.S. Wang S.C. FitzSimmons L.A. O'Leary M.J. Rock M.L. Gwinn M.J. Khoury Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: A registry-based longitudinal study Pediatrics 107 2001 274-279
3. B. Frederiksen C. Koch N. Hoiby Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis Pediatr Pulmonol 23 1997 330-335
4. M. Griese I. Muller D. Reinhardt Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis Eur J Med Res 7 2002 79-80
5. J.M. Littlewood M.G. Miller A.T. Ghoneim C.H. Ramsden Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis Lancet 1 1985 865
6. F. Ratjen G. Doring W.H. Nikolaizik Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis Lancet 358 2001 983-984
7. H.G. Wiesemann G. Steinkamp F. Ratjen A. Bauernfeind B. Przyklenk G. Doring et al. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis Pediatr Pulmonol 25 1998 88-92
8. N.H. Valerius C. Koch N. Hoiby Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment Lancet 338 1991 725-726
9. E. Drenkard F.M. Ausubel Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation Nature 416 2002 740-743
10. M.R. Kosorok M. Jalaluddin P.M. Farrell G. Shen C.E. Colby A. Laxova et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis Pediatr Pulmonol 26 1998 81-88
11. J.L. Burns R.L. Gibson S. McNamara D. Yim J. Emerson M. Rosenfeld et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis J Infect Dis 183 2001 444-452
12. L.V. Silva Filho A.F. Tateno L.F. Velloso J.E. Levi S. Fernandes C.N. Bento et al. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR Pediatr Pulmonol 37 2004 537-547
13. J. Xu J.E. Moore P.G. Murphy B.C. Millar J.S. Elborn Early detection of Pseudomonas aeruginosa-comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF) Ann Clin Microbiol Antimicrob 3 2004 21
14. X. Qin J. Emerson J. Stapp L. Stapp P. Abe J.L. Burns Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli from patients with cystic fibrosis J Clin Microbiol 41 2003 4312-4317
15. M.M. Brett A.T. Ghoneim J.M. Littlewood Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: A follow-up study J Clin Microbiol 26 1988 1565-1570
16. S.E. West L. Zeng B.L. Lee M.R. Kosorok A. Laxova M.J. Rock et al. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: Early detection by serology and assessment of risk factors JAMA 287 2002 2958-2967
17. M. Rosenfeld J. Emerson F. Accurso D. Armstrong R. Castile K. Grimwood et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis Pediatr Pulmonol 28 1999 321-328
18. D.S. Armstrong K. Grimwood J.B. Carlin R. Carzino A. Olinsky P.D. Phelan Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis Pediatr Pulmonol 21 1996 267-275
19. B.W. Ramsey K.R. Wentz A.L. Smith M. Richardson J. Williams-Warren D.L. Hedges et al. Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients Am Rev Respir Dis 144 1991 331-337
20. J.C. Furness A. Habeb D.A. Spencer C.J. O'Brien To the editor: bronchoalveolar lavage (BAL) in pediatric cystic fibrosis (CF): Its clinical use modified by audit in a regional CF center Pediatr Pulmonol 33 2002 234
21. A.C. Equi S.E. Pike J. Davies A. Bush Use of cough swabs in a cystic fibrosis clinic Arch Dis Child 85 2001 438-439
22. R.P. Baughman D.A. Keeton C. Perez R.W. Wilmott Use of bronchoalveolar lavage semiquantitative cultures in cystic fibrosis Am J Respir Crit Care Med 156 1997 286-291
23. M.J. Thomassen J.D. Klinger S.J. Badger D.W. van Heeckeren R.C. Stern Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis J Pediatr 104 1984 352-356
24. K. De Boeck M. Alifier S. Vandeputte Sputum induction in young cystic fibrosis patients Eur Respir J 16 2000 91-94
25. P.G. Gibson D.C. Grootendor R.L. Henry I. Pin P.H. Rytila P. Wark et al. Sputum induction in children Eur Respir J Suppl 37 2002 44s-46s
26. N.R. Henig M.R. Tonelli M.V. Pier J.L. Burns M.L. Aitken Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis Thorax 56 2001 306-311
27. R. Suri L.J. Marshall C. Wallis C. Metcalfe J.K. Shute A. Bush Safety and use of sputum induction in children with cystic fibrosis Pediatr Pulmonol 35 2003 309-313
28. C.L. Ordonez A.I. Kartashov M.E. Wohl Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis J Pediatr 145 2004 689-692
29. S.D. Sagel R. Kapsner I. Osberg M.K. Sontag F.J. Accurso Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction Am J Respir Crit Care Med 164 2001 1425-1431
30. S.A. Ho R. Ball L.J. Morrison K.G. Brownlee S.P. Conway Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis Pediatr Pulmonol 38 2004 82-87
31. F. Karpati J. Jonasson Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis Mol Cell Probes 10 1996 397-403
32. T. Spilker T. Coenye P. Vandamme J.J. LiPuma PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients J Clin Microbiol 42 2004 2074-2079
33. M. Hogardt K. Trebesius A.M. Geiger M. Hornef J. Rosenecker J. Heesemann Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients J Clin Microbiol 38 2000 818-825
34. M.M. Brett A.T. Ghoneim J.M. Littlewood An ELISA, to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis J Clin Pathol 41 1988 1130-1134
35. M.M. Brett A.T. Ghoneim J.M. Littlewood Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis Arch Dis Child 61 1986 1114-1120
36. A.E. Hollsing M. Granstrom M.L. Vasil B. Wretlind B. Strandvik Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis J Clin Microbiol 25 1987 1868-1874
37. M. Granstrom A. Ericsson B. Strandvik B. Wretlind O.R. Pavlovskis R. Berka et al. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis Acta Paediatr Scand 73 1984 772-777
38. Z. Li M.R. Kosorok P.M. Farrell A. Laxova S.E. West C.G. Green et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis JAMA 293 2005 581-588
39. N. Hoiby J.B. Hertz Quantitative studies on immunologically specific and non-specific absorption of Pseudomonas aeruginosa antibodies in serum from cystic fibrosis patients Acta Pathol Microbiol Scand [C] 89 1981 185-192
40. M.M. Brett A.T. Ghoneim J.M. Littlewood Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection Arch Dis Child 62 1987 357-361
41. H.K. Johansen L. Norregaard P.C. Gotzsche T. Pressler C. Koch N. Hoiby Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success? - A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection Pediatr Pulmonol 37 2004 427-432
42. N. Hoiby Antibodies against Pseudomonas aeruginosa in serum from normal persons and patients colonized with mucoid or non-mucoid Pseudomonas aeruginosa: Results obtained by crossed immunoelectrophoresis Acta Pathol Microbiol Scand [C] 85 1977 142-148
43. E.A. Trafny J. Grzybowski J. Patzer D. Popiel J. Wrembel-Wargocka D. Dzierzanowska et al. Characterization of antibody response to Pseudomonas aeruginosa in patients with wound infections Microbiol Immunol 35 1991 435-442
44. L. Danielsen H. Westh E. Balselv V.T. Rosdahl G. Doring Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers Lancet 347 1996 265
45. M.M. Brett A.T. Ghoneim J.M. Littlewood Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis Arch Dis Child 65 1990 259-263
46. G. Cukor N.R. Blacklow N.A. Nowak C.M. Rich L.E. Braverman R.A. Fischer Comparative analysis of serum antibody responses to Pseudomonas aeruginosa exotoxin A by cystic fibrosis and intensive care unit patients J Clin Microbiol 18 1983 457-462
47. G. Kronborg A. Fomsgaard C. Galanos M.A. Freudenberg N. Hoiby Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients J Clin Microbiol 30 1992 1848-1855
48. K. de Boeck E. Eggermont M. Smet P. van Reempts H.P. Van Bever W.J. Stevens Specific decrease of anti-pseudomonal IgA after anti-pseudomonal therapy in cystic fibrosis Eur J Pediatr 154 1995 157-160
49. M.M. Brett E.J. Simmonds A.T. Ghoneim J.M. Littlewood The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis Arch Dis Child 67 1992 1086-1088
50. S.S. Pedersen F. Espersen N. Hoiby Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay J Clin Microbiol 25 1987 1830-1836
51. S.E. West L. Zeng B.L. Lee M.R. Kosorok A. Laxova M.J. Rock et al. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: Early detection by serology and assessment of risk factors JAMA 287 2002 2958-2967